Thursday, June 08, 2017 6:13:44 AM
The market liked when 3 patients were enrolled at the .35 dose. So now that we have surpassed the success of the 1990's trials lets see how the market likes 6 more going in to get the buisness at the listed theraputic dose.
THINK THAT MIGHT CHURN A FEW MORE WARRENTS? AND EXTENED OUR FUNDING BY MORE MONTHS. WELL WE KNOW IT SURE DID WITH OUR FIRST THREE PATIENTS.
http://ww4.fscwire.com/sites/default/files/news_release_pdf/Theralase05262017.pdf
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM